Dren Bio
PrivateLast Round
Corporate Funding
Jul 24, 2024
Total Funding Raised
$156M
Company Overview
Dren Bio is a biotechnology company that develops therapeutic antibodies designed to selectively target and deplete pathogenic cells and disease-causing agents for the treatment of cancer, autoimmune disorders, and other serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dren Bio Comparables
Compare Dren Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| UCB | 85% | |
| Abcuro | 84% | |
| Zenas BioPharma | 77% | |
Dren Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 24, 2024 | ||||
| Series B | Jun 14, 2022 | ||||
| Series A | Oct 16, 2020 | ||||
| Seed | Jul 1, 2019 |
Key People
Founding team and executive leadership
Dren Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiho Ventures | Series B, Series A |
| ArrowMark Partners | Series B |
| HBM Healthcare Investments | Series A, Series B |
| BVF Partners L.P. | Series B, Series A |
| Alexandria Venture Investments | Series B, Series A |
| Aisling Capital | Series B |
| 8VC | Series B, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Launched proprietary platform for developing multispecific antibodies.
- Apr 1, 2026
Lead candidate dibotatug (DR-01) is in clinical development.
Dren Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dren Bio's valuation, stock price, and market status.